Open Access. Powered by Scholars. Published by Universities.®

Pharmacy and Pharmaceutical Sciences Commons™

Open Access. Powered by Scholars. Published by Universities.®

9,492 Full-Text Articles 22,962 Authors 4,797,521 Downloads 273 Institutions

All Articles in Pharmacy and Pharmaceutical Sciences

Faceted Search

9,492 full-text articles. Page 192 of 428.

D04. Department Of Pharmaceutics And Drug Delivery, Michael A. Repka, Walt G. Chambliss, Soumyajit Majumdar, S. N. Murthy, Seong Bong Jo, Chalet Tan, Mahavir Chougule, Eman Ashour 2020 University of Mississippi

D04. Department Of Pharmaceutics And Drug Delivery, Michael A. Repka, Walt G. Chambliss, Soumyajit Majumdar, S. N. Murthy, Seong Bong Jo, Chalet Tan, Mahavir Chougule, Eman Ashour

Annual Poster Session 2020

Corresponding author (Pharmaceutics and Drug Delivery): Eman Ashour, [email protected]


R07. Identification Of Antifungal Bisphosphocholines From Medicinal Gentiana Species, Xing-Cong Li, Siyu Ren, Kejun Deng, Shi Qiu, Mei Wang, Bharathi Avula, Siddharth K. Tripathi, Melissa R. Jacob, Limin Gong, Wei Wang, Ikhlas A. Khan 2020 University of Mississippi

R07. Identification Of Antifungal Bisphosphocholines From Medicinal Gentiana Species, Xing-Cong Li, Siyu Ren, Kejun Deng, Shi Qiu, Mei Wang, Bharathi Avula, Siddharth K. Tripathi, Melissa R. Jacob, Limin Gong, Wei Wang, Ikhlas A. Khan

Annual Poster Session 2020

Corresponding author (NCNPR): Xing-Cong Li, [email protected]


R13. Formulation Development Of Loratadine Immediate-Release Tablets Using Hot-Melt Extrusion Coupled With 3d-Printing Technology, Sundus Hussain Omari, Eman A. Ashour, Mashan Amutairi, Rasha Elkanayati, Michael A. Repka 2020 University of Mississippi

R13. Formulation Development Of Loratadine Immediate-Release Tablets Using Hot-Melt Extrusion Coupled With 3d-Printing Technology, Sundus Hussain Omari, Eman A. Ashour, Mashan Amutairi, Rasha Elkanayati, Michael A. Repka

Annual Poster Session 2020

Corresponding author (Pharmaceutics and Drug delivery): Sundus Hussain Omari, [email protected]


R11. Challenges And Future Directions Of Potential Natural Products Leads Against 2019-Ncov Outbreak, Meirambek Ospanov, Francisco León, Janar Jenis, Ikhlas A. Khan, Mohamed A. Ibrahim 2020 University of Mississippi

R11. Challenges And Future Directions Of Potential Natural Products Leads Against 2019-Ncov Outbreak, Meirambek Ospanov, Francisco León, Janar Jenis, Ikhlas A. Khan, Mohamed A. Ibrahim

Annual Poster Session 2020

Corresponding author (NCNPR): Mohamed A. Ibrahim, [email protected]


R08. Characterization Of Key Metabolites In Serum Of Fuzheng Huayu Phase Ii Clinical Trial, Yan-Hong Wang, ZaChara Catchings, Bharathi Avula, Mei Wang, Huashi Bian, Ikhlas A. Khan 2020 University of Mississippi

R08. Characterization Of Key Metabolites In Serum Of Fuzheng Huayu Phase Ii Clinical Trial, Yan-Hong Wang, Zachara Catchings, Bharathi Avula, Mei Wang, Huashi Bian, Ikhlas A. Khan

Annual Poster Session 2020

Corresponding author (NCNPR): Yan-Hong Wang, [email protected]


R03. Hiv Tat Protein Activates Plasma Kallikrein-Kinin System In The Doxycycline-Inducible Astrocyte Specific Hiv-1 Tat Transgenic Mice, Logan Sneed, Fakhri Mahdi, Salahoddin Mohamed, Jason J. Paris, Zia Shariat-Madar 2020 University of Mississippi

R03. Hiv Tat Protein Activates Plasma Kallikrein-Kinin System In The Doxycycline-Inducible Astrocyte Specific Hiv-1 Tat Transgenic Mice, Logan Sneed, Fakhri Mahdi, Salahoddin Mohamed, Jason J. Paris, Zia Shariat-Madar

Annual Poster Session 2020

Corresponding author (BioMolecular Sciences): Logan Sneed, [email protected]


R18. Preparation And Characterization Of Pegylated Nanostructured Lipid Carrier Systems For The Ocular Delivery Of Antineoplastic Agent, Sushrut Marathe, Narender Dudhipala, Soumyajit Majumdar 2020 University of Mississippi

R18. Preparation And Characterization Of Pegylated Nanostructured Lipid Carrier Systems For The Ocular Delivery Of Antineoplastic Agent, Sushrut Marathe, Narender Dudhipala, Soumyajit Majumdar

Annual Poster Session 2020

Corresponding author (Pharmaceutics and Drug delivery): Sushrut Marathe, [email protected]


D02. Ncnpr Activities At Coy Waller Complex, Mahmoud A. ElSohly, Suman Chandra, Mohamed M. Radwan, Hemant Lata, Amira Wanas, Chandrani G. Majumdar 2020 University of Mississippi

D02. Ncnpr Activities At Coy Waller Complex, Mahmoud A. Elsohly, Suman Chandra, Mohamed M. Radwan, Hemant Lata, Amira Wanas, Chandrani G. Majumdar

Annual Poster Session 2020

Corresponding author (NCNPR, School of Pharmacy): Mohamed M. Radwan, [email protected]


R06. Identification Of The Cellular Pathways Targeted By Two Antifungal Natural Products Using Rna-Seq Analysis, Ameeta K. Agarwal, Siddharth K. Tripathi, Qin Feng, Ranga Rao Ravu, Xing-Cong Li, Alice M. Clark 2020 University of Mississippi

R06. Identification Of The Cellular Pathways Targeted By Two Antifungal Natural Products Using Rna-Seq Analysis, Ameeta K. Agarwal, Siddharth K. Tripathi, Qin Feng, Ranga Rao Ravu, Xing-Cong Li, Alice M. Clark

Annual Poster Session 2020

Corresponding author (NCNPR): Ameeta Agarwal, [email protected]


R09. New Atractylon Derivatives Generated In Processed Rhizomes Of Atractylodes Macrocephala Koidz, Chunmei Zhai, Jianping Zhao, Amar G. Chittiboyina, Yonghai Meng, Mei Wang, Ikhlas A. Khan 2020 University of Mississippi; Heilongjiang University of Chinese Medicine, (People's Republic of China)

R09. New Atractylon Derivatives Generated In Processed Rhizomes Of Atractylodes Macrocephala Koidz, Chunmei Zhai, Jianping Zhao, Amar G. Chittiboyina, Yonghai Meng, Mei Wang, Ikhlas A. Khan

Annual Poster Session 2020

Corresponding author (NCNPR): Jianping Zhao, [email protected]


R15. Development And Characterization Of Hot-Melt Extruded Ocular Inserts Of Moxifloxacin For Bacterial Keratitis, Ruchi Thakkar, Nagireddy Dumpa, Narendar Dudhipala, Michael A. Repka, Soumyajit Majumdar 2020 University of Mississippi

R15. Development And Characterization Of Hot-Melt Extruded Ocular Inserts Of Moxifloxacin For Bacterial Keratitis, Ruchi Thakkar, Nagireddy Dumpa, Narendar Dudhipala, Michael A. Repka, Soumyajit Majumdar

Annual Poster Session 2020

Corresponding author (Pharmaceutics and Drug delivery): Ruchi Thakkar, [email protected]


R21. Preparation, Characterization And Stability Evaluation Of Ligand Anchored Primaquine Loaded Nanostructured Lipid Carrier Systems For Liver Targeting, Tabish Mehraj, Samir Senapati, Sushrut Marathe, Narendar Dudhipala, Babulal Tekwani, Soumyajit Majumdar 2020 University of Mississippi

R21. Preparation, Characterization And Stability Evaluation Of Ligand Anchored Primaquine Loaded Nanostructured Lipid Carrier Systems For Liver Targeting, Tabish Mehraj, Samir Senapati, Sushrut Marathe, Narendar Dudhipala, Babulal Tekwani, Soumyajit Majumdar

Annual Poster Session 2020

Corresponding author (Pharmaceutics and Drug delivery): Tabish Mehraj, [email protected]


R10. First In Class (S,E)-11-[2-(Arylmethylene)Hydrazono]-Pbd Analogs As Selective Cb2 Modulators Targeting Neurodegenerative Disorders, Meirambek Ospanov, David Mingle, Mohamed O. Radwan, Nicole M. Ashpole, Masami Otsuka, Samir A. Ross, Larry A. Walker, Abbas G. Shilabin, Mohamed A. Ibrahim 2020 University of Mississippi

R10. First In Class (S,E)-11-[2-(Arylmethylene)Hydrazono]-Pbd Analogs As Selective Cb2 Modulators Targeting Neurodegenerative Disorders, Meirambek Ospanov, David Mingle, Mohamed O. Radwan, Nicole M. Ashpole, Masami Otsuka, Samir A. Ross, Larry A. Walker, Abbas G. Shilabin, Mohamed A. Ibrahim

Annual Poster Session 2020

Corresponding author (NCNPR): Mohamed A. Ibrahim, [email protected]


R23. Demographics And Outcomes Of Patients Hospitalized For Covid-19, Jonathan T. Newbaker, Scott S. Malinowski 2020 University of Mississippi Medical Center

R23. Demographics And Outcomes Of Patients Hospitalized For Covid-19, Jonathan T. Newbaker, Scott S. Malinowski

Annual Poster Session 2020

Corresponding author (University of Mississippi Medical Center): Jonathan T. Newbaker, [email protected]


Synthesis, In Vitro, And In Vivo Evaluation Of Novel N-Phenylindazolyl Diarylureas As Potential Anti-Cancer Agents., Lucas N Solano, Grady L Nelson, Conor T Ronayne, Shirisha Jonnalagadda, Sravan K Jonnalagadda, Kaija Kottke, Robert Chitren, Joseph L Johnson, Manoj K Pandey, Subash C. Jonnalagadda, Venkatram R Mereddy 2020 Rowan University

Synthesis, In Vitro, And In Vivo Evaluation Of Novel N-Phenylindazolyl Diarylureas As Potential Anti-Cancer Agents., Lucas N Solano, Grady L Nelson, Conor T Ronayne, Shirisha Jonnalagadda, Sravan K Jonnalagadda, Kaija Kottke, Robert Chitren, Joseph L Johnson, Manoj K Pandey, Subash C. Jonnalagadda, Venkatram R Mereddy

College of Science & Mathematics Departmental Research

Novel N-phenylindazole based diarylureas have been designed, synthesized and evaluated as potential anticancer agents. In vitro cell viability studies of these derivatives illustrate good potency with IC50 values in the range of 0.4–50 μM in several cancer cell lines including murine metastatic breast cancer 4T1, murine glioblastoma GL261, human triple negative breast cancer MDA-MB-231, human pancreatic cancer MIAPaCa-2, and human colorectal cancer cell line WiDr. The ester group in the lead compound 8i was modified to incorporate amino-amides to increase solubility and stability while retaining biological activity. Further in vitro studies reveal that lead candidates inhibit tube length in HUVEC …


Analysis Of Kshv B Lymphocyte Lineage Tropism In Human Tonsil Reveals Efficient Infection Of Cd138+ Plasma Cells, Farizeh Aalam, Ramina Nabiee, Jesus Ramirez Castano, Jennifer Totonchy 2020 Chapman University

Analysis Of Kshv B Lymphocyte Lineage Tropism In Human Tonsil Reveals Efficient Infection Of Cd138+ Plasma Cells, Farizeh Aalam, Ramina Nabiee, Jesus Ramirez Castano, Jennifer Totonchy

Pharmacy Faculty Articles and Research

Despite 25 years of research, the basic virology of Kaposi Sarcoma Herpesviruses (KSHV) in B lymphocytes remains poorly understood. This study seeks to fill critical gaps in our understanding by characterizing the B lymphocyte lineage-specific tropism of KSHV. Here, we use lymphocytes derived from 40 human tonsil specimens to determine the B lymphocyte lineages targeted by KSHV early during de novo infection in our ex vivo model system. We characterize the immunological diversity of our tonsil specimens and determine that overall susceptibility of tonsil lymphocytes to KSHV infection varies substantially between donors. We demonstrate that a variety of B lymphocyte …


Cyclosporine Shows Benefit As Compared To Methotrexate For Treatment Of Pediatric Atopic Dermatitis Refractory To Topical Medications When Rapidity Of Clinical Response Is Of Key Importance To The Patient, Connor R. Buechler, Steven Daveluy MD 2020 Wayne State University School of Medicine

Cyclosporine Shows Benefit As Compared To Methotrexate For Treatment Of Pediatric Atopic Dermatitis Refractory To Topical Medications When Rapidity Of Clinical Response Is Of Key Importance To The Patient, Connor R. Buechler, Steven Daveluy Md

Clinical Research in Practice: The Journal of Team Hippocrates

A clinical decision report appraising El-Khalawany MA, Hassan H, Shaaban D, Ghonaim N, Eassa B. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. European Journal of Pediatrics. 2012;172(3):351-356. https://doi.org10.1007/s00431-012-1893-3 for a pediatric patient with severe atopic dermatitis.


What’S The Big Deal About Statins?, Albert Bach, Jelena Lewis, Susie Yoo 2020 Chapman University

What’S The Big Deal About Statins?, Albert Bach, Jelena Lewis, Susie Yoo

Pharmacy Faculty Articles and Research

"Statins are a group of cholesterol-lowering medications that have been shown evidence to be beneficial for tens of millions of Americans. Some examples of statin medications you may have heard of include: atorvastatin (Lipitor), rosuvastatin (Crestor), simvastatin (Zocor), pravastatin (Pravachol) and lovastatin (Mevacor). Statins are one of the most commonly prescribed medications in the United States. One in four adults over the age of 45 years old are currently taking a statin for its many benefits. See below for more information about its use."


Lc–Ms/Ms-Based In Vitro And In Vivo Investigation Of Blood–Brain Barrier Integrity By Simultaneous Quantitation Of Mannitol And Sucrose, Behnam Noorani, Ekram Ahmed Chowdhury, Faleh Alqahtani, Yeseul Ahn, Dhavalkumar Patel, Abraham Al-Ahmad, Reza Mehvar, Ulrich Bickel 2020 Texas Tech University Health Sciences Center

Lc–Ms/Ms-Based In Vitro And In Vivo Investigation Of Blood–Brain Barrier Integrity By Simultaneous Quantitation Of Mannitol And Sucrose, Behnam Noorani, Ekram Ahmed Chowdhury, Faleh Alqahtani, Yeseul Ahn, Dhavalkumar Patel, Abraham Al-Ahmad, Reza Mehvar, Ulrich Bickel

Pharmacy Faculty Articles and Research

Background

Understanding the pathophysiology of the blood brain–barrier (BBB) plays a critical role in diagnosis and treatment of disease conditions. Applying a sensitive and specific LC–MS/MS technique for the measurement of BBB integrity with high precision, we have recently introduced non-radioactive [13C12]sucrose as a superior marker substance. Comparison of permeability markers with different molecular weight, but otherwise similar physicochemical properties, can provide insights into the uptake mechanism at the BBB. Mannitol is a small hydrophilic, uncharged molecule that is half the size of sucrose. Previously only radioactive [3H]mannitol or [14C]mannitol has been …


Overcoming Barriers For Sirna Therapeutics: From Bench To Bedside, Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato, Kayley Yeseom Cho, Rakesh Kumar Tiwari 2020 Chapman University

Overcoming Barriers For Sirna Therapeutics: From Bench To Bedside, Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato, Kayley Yeseom Cho, Rakesh Kumar Tiwari

Pharmacy Faculty Articles and Research

The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their therapeutic use is limited by several challenges. siRNAs, being negatively charged, are membrane-impermeable and highly unstable in the systemic circulation. In this review, we have comprehensively discussed the extracellular barriers, including enzymatic degradation of siRNAs by serum endonucleases and RNAases, rapid renal clearance, membrane impermeability, and activation of the immune system. Besides, we have thoroughly described …


Digital Commons powered by bepress